Memorial Hospital Research Laboratories
The Tobias Hohl Lab
Research

Associate Attending
We investigate the immune response to human fungal pathogens and, conversely, the mechanisms that enable fungi to cause infectious diseases. To illuminate these processes, we generate fluorescent-based tools to monitor the outcome of fungal cell – host cell encounters and examine the role of both inhaled fungal spores and of endogenous fungal communities, termed the mycobiome, in fungal disease development.


Featured News
Publications
People

Tobias M. Hohl, MD, PhD
Chief, Infectious Diseases Service
Associate Attending
- Physician-scientist Tobias Hohl studies the molecular pathogenesis of human fungal pathogens and how the immune system responds to them.
- MD, Weill Medical College of Cornell University
- PhD, Weill Graduate School of Medical Sciences of Cornell University
- hohlt@mskcc.org
- Email Address
- View physician profile
- Physician profile
Members

- Stony Brook University

- Weill Cornell Graduate School of Medical Sciences

- BS, Columbia University


Graduate Student

Research Technician

Research Fellow

Chief

Graduate Student


Life Sciences Specialist at L.E.K Consulting, New York, NY

Research Technician

Administrative Assistant

Research Fellow



- PhD, Tel Aviv University
Lab Alumni

Research Fellow

Senior Research Technician

Assistant Professor

Postdoctoral Fellow

Research Technician

Research Associate

Assistant Professor

Administrative Assistant
Lab Affilations
Achievements
- Member, American Society of Clinical Investigation (2016)
- Investigator in the Pathogenesis of Infectious Diseases, Burrroughs Wellcome Fund (2014)
- Fellow, Infectious Diseases Society of America (2012)
- Young Investigator Award, American Society of Microbiology (2009)
Open Positions
Career Opportunities
Get in Touch
-
Lab Head Email
-
Lab Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Tobias M. Hohl discloses the following relationships and financial interests:
-
Merck & Co Inc.
Provision of Services -
Partner Therapeutics, Inc.
Provision of Services
-
Portola Pharmaceuticals
Provision of Services (uncompensated)
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.